Patents by Inventor William J. Hennen

William J. Hennen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12059446
    Abstract: A composition for supporting metabolism or the endocrine system of a subject includes transfer factor and one or more support components. The transfer factor is useful for preventing, mitigating the effects of, or reversing autoimmunity, as well as for preventing, mitigating the effects or, or reversing oxidative stress. The one or more support components may prevent misregulation of or facilitate regulation of metabolism or endocrine system of the subject. A support or treatment method includes administering transfer factor to a subject, with or without one or more support components.
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: August 13, 2024
    Assignee: 4Life Patents, LLC
    Inventors: Calvin W. McCausland, Brent Vaughan, William J. Hennen, David A. Lisonbee
  • Publication number: 20220112256
    Abstract: A composition for eliciting a T-cell mediated immune response in a subject includes transfer factor from at least two different types of source animals. For example, the composition may include mammalian transfer factor and nonmammalian transfer factor. An example of the composition includes a combination of a colostrum-derived product, which includes the mammalian transfer factor, and an egg-derived product, which includes the nonmammalian transfer factor. Additionally, the egg-derived product may be substantially free of fat. Methods for forming the composition and eliciting T-cell mediated immune responses in subjects that have been treated with the composition are also disclosed.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 14, 2022
    Inventors: David Lisonbee, William J. Hennen, F. Joseph Daugherty
  • Patent number: 11203625
    Abstract: A composition for eliciting a T-cell mediated immune response in a subject includes transfer factor from at least two different types of source animals. For example, the composition may include mammalian transfer factor and nonmammalian transfer factor. An example of the composition includes a combination of a colostrum-derived product, which includes the mammalian transfer factor, and an egg-derived product, which includes the nonmammalian transfer factor. Additionally, the egg-derived product may be substantially free of fat. Methods for forming the composition and eliciting T-cell mediated immune responses in subjects that have been treated with the composition are also disclosed.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: December 21, 2021
    Assignee: 4LIFE PATENTS, LLC
    Inventors: David Lisonbee, William J. Hennen, F. Joseph Daugherty
  • Patent number: 10905732
    Abstract: A drink includes an edible liquid or semisolid preparation and transfer factor. The drink may also include lactoferrin and one or more preservatives. An edible preparation includes a fruit component and transfer factor. The fruit component may include at least one oligoproanthocyanidin-containing fruit. The edible preparation may also include lactoferrin. One or more preservatives may also be included in the edible preparation. The drink or the edible preparation may be sterilized or pasteurized.
    Type: Grant
    Filed: May 1, 2018
    Date of Patent: February 2, 2021
    Assignee: 4Life Patents, LLC
    Inventors: Calvin W. McCausland, Brent Vaughan, David Lisonbee, William J. Hennen
  • Patent number: 10583168
    Abstract: A composition for use in cardiovascular support includes transfer factor. The transfer factor may be nonmammalian transfer factor, such as that derived from eggs, or mammalian transfer factor, such as that derived from colostrum. The composition may also include one or more of the following: an LDL receptor-binding element; a blood flow-enhancing element; a cholesterol reducing element; a fat oxidation prevention element, and an antioxidant. Treatment methods include enlisting the immune system of a subject receiving therapy to attack pathogens that cause inflammation of blood vessels or to otherwise reduce inflammation of blood vessels.
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: March 10, 2020
    Assignee: 4Life Patents, LLC
    Inventor: William J. Hennen
  • Publication number: 20200062815
    Abstract: A composition for eliciting a T-cell mediated immune response in a subject includes transfer factor from at least two different types of source animals. For example, the composition may include mammalian transfer factor and nonmammalian transfer factor. An example of the composition includes a combination of a colostrum-derived product, which includes the mammalian transfer factor, and an egg-derived product, which includes the nonmammalian transfer factor. Additionally, the egg-derived product may be substantially free of fat. Methods for forming the composition and eliciting T-cell mediated immune responses in subjects that have been treated with the composition are also disclosed.
    Type: Application
    Filed: November 4, 2019
    Publication date: February 27, 2020
    Inventors: David Lisonbee, William J. Hennen, F. Joseph Daugherty
  • Publication number: 20180318369
    Abstract: A drink includes an edible liquid or semisolid preparation and transfer factor. The drink may also include lactoferrin and one or more preservatives. An edible preparation includes a fruit component and transfer factor. The fruit component may include at least one oligoproanthocyanidin-containing fruit. The edible preparation may also include lactoferrin. One or more preservatives may also be included in the edible preparation. The drink or the edible preparation may be sterilized or pasteurized.
    Type: Application
    Filed: May 1, 2018
    Publication date: November 8, 2018
    Inventors: Calvin W. McCausland, Brent Vaughan, David Lisonbee, William J. Hennen
  • Patent number: 9849157
    Abstract: A composition for use in cardiovascular therapy includes transfer factor. The transfer factor may be nonmammalian transfer factor, such as that derived from eggs, or mammalian transfer factor, such as that derived from colostrum. The composition may also include one or more of the following: an LDL receptor-binding element; a blood flow-enhancing element; a cholesterol reducing element; a fat oxidation prevention element, and an antioxidant. Treatment methods include enlisting the immune system of a subject receiving therapy to attack pathogens that cause inflammation of blood vessels or to otherwise reduce inflammation of blood vessels.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: December 26, 2017
    Assignee: 4LIFE PATENTS, LLC
    Inventor: William J. Hennen
  • Publication number: 20130309268
    Abstract: A non-mammalian transfer factor, compositions including the non-mammalian transfer factor, and methods for generating and preparing the non-mammalian transfer factor. The non-mammalian transfer factor may have specificity for one or more antigens. A method of using the non-mammalian transfer factor includes administering either antigen-specific non-mammalian transfer factor or antigen non-specific non-mammalian transfer factor to mammals to treat or prevent pathogenic infections in the mammals.
    Type: Application
    Filed: February 22, 2002
    Publication date: November 21, 2013
    Inventors: William J. Hennen, David T. Lisonbee
  • Publication number: 20110033414
    Abstract: A composition for use in cardiovascular therapy includes transfer factor. The transfer factor may be nonmammalian transfer factor, such as that derived from eggs, or mammalian transfer factor, such as that derived from colostrum. The composition may also include one or more of the following: an LDL receptor-binding element; a blood flow-enhancing element; a cholesterol reducing element; a fat oxidation prevention element, and an antioxidant. Treatment methods include enlisting the immune system of a subject receiving therapy to attack pathogens that cause inflammation of blood vessels or to otherwise reduce inflammation of blood vessels.
    Type: Application
    Filed: October 18, 2010
    Publication date: February 10, 2011
    Applicant: 4LIFE RESEARCH, LC
    Inventor: William J. Hennen
  • Patent number: 7815943
    Abstract: A composition for use in cardiovascular therapy includes transfer factor. The transfer factor may be nonmammalian transfer factor, such as that derived from eggs, or mammalian transfer factor, such as that derived from colostrum. The composition may also include one or more of the following: an LDL receptor-binding element; a blood flow-enhancing element; a cholesterol reducing element; a fat oxidation prevention element, and an antioxidant. Treatment methods include enlisting the immune system of a subject receiving therapy to attack pathogens that cause inflammation of blood vessels or to otherwise reduce inflammation of blood vessels.
    Type: Grant
    Filed: August 22, 2003
    Date of Patent: October 19, 2010
    Assignee: 4Life Research, LC
    Inventor: William J. Hennen
  • Patent number: 6866868
    Abstract: A composition for eliciting a T-cell mediated immune response in a subject includes transfer factor from at least two different types of source animals. For example, the composition may include mammalian transfer factor and nonmammalian transfer factor. An example of the composition includes a combination of a colostrum-derived product, which includes the mammalian transfer factor, and an egg-derived product, which includes the nonmammalian transfer factor. Additionally, the egg-derived product may be substantially free of fat. Methods for forming the composition and eliciting T-cell mediated immune responses in subjects that have been treated with the composition are also disclosed.
    Type: Grant
    Filed: September 15, 2003
    Date of Patent: March 15, 2005
    Assignee: 4Life Research, LC
    Inventors: David Lisonbee, William J. Hennen, F. Joseph Daugherty
  • Publication number: 20040126432
    Abstract: A composition for use in cardiovascular therapy includes transfer factor. The transfer factor may be nonmammalian transfer factor, such as that derived from eggs, or mammalian transfer factor, such as that derived from colostrum. The composition may also include one or more of the following: an LDL receptor-binding element; a blood flow-enhancing element; a cholesterol reducing element; a fat oxidation prevention element, and an antioxidant. Treatment methods include enlisting the immune system of a subject receiving therapy to attack pathogens that cause inflammation of blood vessels or to otherwise reduce inflammation of blood vessels.
    Type: Application
    Filed: August 22, 2003
    Publication date: July 1, 2004
    Inventor: William J. Hennen
  • Publication number: 20030031686
    Abstract: An egg-derived transfer factor, compositions including the egg-derived transfer factor, and methods for generating and preparing the egg-derived transfer factor. The egg-derived transfer factor may have specificity for one or more antigens. A method of using the egg-derived transfer factor includes administering either antigen-specific egg-derived transfer factor or antigen non-specific egg-derived transfer factor to animals, such as mammals, to treat or prevent pathogenic infections in the animals.
    Type: Application
    Filed: March 21, 2002
    Publication date: February 13, 2003
    Inventors: William J. Hennen, David T. Lisonbee
  • Publication number: 20020182216
    Abstract: A non-mammalian transfer factor, compositions including the non-mammalian transfer factor, and methods for generating and preparing the non-mammalian transfer factor. The non-mammalian transfer factor may have specificity for one or more antigens. A method of using the non-mammalian transfer factor includes administering either antigen-specific non-mammalian transfer factor or antigen non-specific non-mammalian transfer factor to mammals to treat or prevent pathogenic infections in the mammals.
    Type: Application
    Filed: February 22, 2002
    Publication date: December 5, 2002
    Inventors: William J. Hennen, David T. Lisonbee
  • Patent number: 6468534
    Abstract: A non-mammalian transfer factor, compositions including the non-mammalian transfer factor, and methods for generating and preparing the non-mammalian transfer factor. The non-mammalian transfer factor may have specificity for one or more antigens. A method of using the non-mammalian transfer factor includes administering either antigen-specific non-mammalian transfer factor or antigen non-specific non-mammalian transfer factor to mammals to treat or prevent pathogenic infections in the mammals.
    Type: Grant
    Filed: September 21, 2000
    Date of Patent: October 22, 2002
    Assignee: 4Life Research, LC
    Inventors: William J. Hennen, David T. Lisonbee
  • Patent number: 5554771
    Abstract: The present invention relates to 2-deoxy-N-acetylneuraminic acid derivatives and methods for their preparation.
    Type: Grant
    Filed: August 16, 1995
    Date of Patent: September 10, 1996
    Assignee: G. D. Searle & Co.
    Inventors: Chi-Huey Wong, William J. Hennen
  • Patent number: 5239091
    Abstract: The present invention relates to 2-deoxy-N-acetyl-neuraminic acid derivatives and methods for their preparation.
    Type: Grant
    Filed: November 7, 1991
    Date of Patent: August 24, 1993
    Assignee: G. D. Searle & Co.
    Inventors: Chi-Huey Wong, William J. Hennen
  • Patent number: 5106750
    Abstract: A process for irreversible regio- and stereoselective enzyme catalyzed acylation of alcohols using enol esters as acylating reagents is disclosed. The present invention permits the selective modification of hydroxyl group(s) of chiral and meso alcohols, including sugars, organometallics, and glycosides. The enol freed upon transesterification rapidly tautomerizes to the corresponding volatile aldehyde or ketone thereby preventing the reverse reaction from occurring.
    Type: Grant
    Filed: August 24, 1989
    Date of Patent: April 21, 1992
    Assignee: G. D. Searle & Co.
    Inventors: Chi-Huey Wong, Yi-Fong Wang, William J. Hennen, Kevin A. Babiak, John H. Dygos, John S. Ng
  • Patent number: 5075225
    Abstract: A process for synthesizing nucleosides is disclosed. The process includes the reaction of an alkylated nucleoside (such as 7-methylguanosine or 7-methylinosine) with a heterocyclic base (such as adenine, 3-deazaadenine or 1,2,4-triazole-3-carboxamide) in the presence of a nucleoside-forming enzyme to form a nucleoside that includes a glycosyl component, donate by the alkylated nucleoside, bonded to the heterocyclic base.
    Type: Grant
    Filed: April 6, 1989
    Date of Patent: December 24, 1991
    Assignee: The Texas A&M University System
    Inventors: Chi-Huey Wong, William J. Hennen